0001209191-14-036356.txt : 20140522
0001209191-14-036356.hdr.sgml : 20140522
20140522182820
ACCESSION NUMBER: 0001209191-14-036356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140521
FILED AS OF DATE: 20140522
DATE AS OF CHANGE: 20140522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 14864973
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-05-21
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
SAN DIEGO
CA
92122
1
1
1
0
President, CEO & Secretary
Common Stock
2014-05-21
4
P
0
12000
7.37
A
20000
I
By children
Common Stock
1391086
D
Represents the weighted-average price at which shares were purchased within a range between $7.259 and $7.669. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2014-05-22